Economic impact of the use of patiromer in chronic kidney disease or heart failure for the treatment of chronic hyperkalemia in Spain

  1. de Sequera, P.
  2. Bover, R.
  3. Ivanova-Markova, Y.
  4. Ivanova, A.
  5. González-Domínguez, A.
  6. Valls, M.
  7. Campos, V.
Aldizkaria:
Nefrologia

ISSN: 2013-2514,  0211-6995

Argitalpen urtea: 2023

Alea: 43

Zenbakia: 6

Orrialdeak: 721-730

Mota: Artikulua

DOI: 10.1016/J.NEFRO.2022.08.007 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus